• Refine Your Search

Trials

Our clinical trials span the continuum of dementia utilizing novel interventions and targets.

Trial Populations

AHEAD Study
PIs:

Reisa Sperling, Paul Aisen, Keith Johnson

View project
A4 Open Label Extension (A4)
PIs:

Reisa Sperling, Paul Aisen

View project
Alzheimer’s Plasma Extension Study (APEX)
PIs:

Reisa Sperling, Paul Aisen, Keith Johnson

View project
Trial Ready Cohort for the Prevention of Alzheimer’s Dementia (TRC-PAD)
PIs:

Paul Aisen, Reisa Sperling, Jeffrey Cummings

View project
Alzheimer’s Tau Platform (ATP) Clinical Trial
PIs:

Adam Boxer, Keith Johnson

View project
Synaptic Therapy Alzheimer’s Research Trial (START)
PIs:

Christopher van Dyck, Anthony Caggiano

View project
Life’s End Benefits of Cannabidiol and Tetrahyrdocannabinol (LiBBY)
PIs:

Jacobo Mintzer, Brigid Reynolds

View project